Aflibercept in combination with FOLFIRI for the second-line treatment of patients with metastatic colorectal cancer: First interim safety data from AFEQT trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreAflibercept in combination with FOLFIRI for the second-line treatment of patients with metastatic colorectal cancer: First interim safety data from AFEQT trial.
Type de publicationJournal Article
Year of Publication2015
AuteursBen Abdelghani M, Borg C, Dourthe L-M, Deplanque G, Taieb J, Metges J-P, Laplaige P, Lotz V, Amrate A, Lledo G
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedJAN 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.3_suppl.661